NDA (New Drug Application)
ANDA (Generic Application)
Track protection status across key markets to assess launch feasibility.
It is formulated by 57 pharmaceutical companies such as TORRENT PHARMS LTD, GRANULES INDIA, HERITAGE and others. It is marketed under 26 brand names, including METFORMIN HYDROCHLORIDE, GLIPIZIDE AND METFORMIN HYDROCHLORIDE, KOMBIGLYZE XR and others. Available in 51 different strengths, such as 750MG, 850MG, 500MG and others, and administered through 4 routes including TABLET, EXTENDED RELEASE;ORAL, TABLET;ORAL, FOR SUSPENSION, EXTENDED RELEASE;ORAL and others.
API availability: Loading API feasibility...
Licensing: 57 potential partnersUS Launch window: Loading launch window...
Stay ahead with worldwide patent expiry and latest updates.
FDA approval history for this ingredient
Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.
Key expiration dates for US patents covering this ingredient
Stay ahead with worldwide patent expiry insights, market data, and research updates.
Latest drug strengths approved by FDA
| Strength | Route of Administration | Companies | Latest Approval Date |
|---|
Patents approved by the FDA for the ingredient
|
|
Patent Number | Publication Date | Legal Status | Patent Expiry Date | |
|---|---|---|---|---|---|
| {"application_id":"95150","ingredient":"ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE","trade_name":"KAZANO","family_id":"a68761525bab406db4fc","publication_number":"US8173663B2","cleaned_patent_number":"8173663","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-15","publication_date":"2012-05-08","legal_status":"Granted"} | US8173663B2 | 08 May, 2012 | Granted | 15 Mar, 2025 | |
| {"application_id":"85081","ingredient":"METFORMIN HYDROCHLORIDE","trade_name":"GLUMETZA","family_id":"d2b91870ba4441269b2d","publication_number":"US7780987B2","cleaned_patent_number":"7780987","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-03-23","publication_date":"2010-08-24","legal_status":"Granted"} | US7780987B2 Molecular Formulation | 24 Aug, 2010 | Granted | 23 Mar, 2025 | |
| {"application_id":"95152","ingredient":"ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE","trade_name":"KAZANO","family_id":"a68761525bab406db4fc","publication_number":"US8288539B2","cleaned_patent_number":"8288539","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-06-24","publication_date":"2012-10-16","legal_status":"Patented case"} | US8288539B2 Molecular | 16 Oct, 2012 | Patented case | 24 Jun, 2025 | |
| {"application_id":"41918","ingredient":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE","trade_name":"KOMBIGLYZE XR","family_id":"2c2dc51a052641d0a70a","publication_number":"US8628799B2","cleaned_patent_number":"8628799","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-07-13","publication_date":"2014-01-14","legal_status":"Patented case"} | US8628799B2 Formulation | 14 Jan, 2014 | Patented case | 13 Jul, 2025 | |
| {"application_id":"129389","ingredient":"METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE","trade_name":"KOMBIGLYZE XR","family_id":"93bf360deec84f4fbecc","publication_number":"US9339472B2","cleaned_patent_number":"9339472","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-07-13","publication_date":"2016-05-17","legal_status":"Patented case"} | US9339472B2 Formulation | 17 May, 2016 | Patented case | 13 Jul, 2025 | |
| {"application_id":"2399","ingredient":"CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"INVOKAMET","family_id":"0034c3920e9647578225","publication_number":"US8222219B2","cleaned_patent_number":"8222219","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-10-11","publication_date":"2012-07-17","legal_status":"Granted"} | US8222219B2 | 17 Jul, 2012 | Granted | 11 Oct, 2025 | |
| {"application_id":"3674","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"d0f4545c1bbb47d3817d","publication_number":"US7407955B2","cleaned_patent_number":"7407955","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2025-11-02","publication_date":"2008-08-05","legal_status":"Patented case"} | US7407955B2 | 05 Aug, 2008 | Patented case | 02 Nov, 2025 | |
| {"application_id":"1315","ingredient":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"QTERNMET XR","family_id":"16d27eafce1142e3979e","publication_number":"US6515117B2","cleaned_patent_number":"6515117","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-04-04","publication_date":"2003-02-04","legal_status":"Patented case"} | US6515117B2 | 04 Feb, 2003 | Patented case | 04 Apr, 2026 | |
| {"application_id":"128938","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"b005fd93319f450e8697","publication_number":"US8883805B2","cleaned_patent_number":"8883805","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-05-26","publication_date":"2014-11-11","legal_status":"Patented case"} | US8883805B2 | 11 Nov, 2014 | Patented case | 26 May, 2026 | |
| {"application_id":"84484","ingredient":"METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","trade_name":"ACTOPLUS MET XR","family_id":"7ced6bfba3614dfcba12","publication_number":"US7785627B2","cleaned_patent_number":"7785627","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-31","publication_date":"2010-08-31","legal_status":"Granted"} | US7785627B2 Formulation | 31 Aug, 2010 | Granted | 31 Jul, 2026 | |
| {"application_id":"84539","ingredient":"METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","trade_name":"ACTOPLUS MET XR","family_id":"7ced6bfba3614dfcba12","publication_number":"US7959946B2","cleaned_patent_number":"7959946","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2026-07-31","publication_date":"2011-06-14","legal_status":"Granted"} | US7959946B2 Formulation | 14 Jun, 2011 | Granted | 31 Jul, 2026 | |
| {"application_id":"89576","ingredient":"METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","trade_name":"ACTOPLUS MET","family_id":"1953db80db614db696b9","publication_number":"US9101660B2","cleaned_patent_number":"9101660","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-01-22","publication_date":"2015-08-11","legal_status":"Granted"} | US9101660B2 Formulation | 11 Aug, 2015 | Granted | 22 Jan, 2027 | |
| {"application_id":"86131","ingredient":"METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","trade_name":"JANUMET","family_id":"4bc8ed0eff3e4fdd986b","publication_number":"US7326708B2","cleaned_patent_number":"7326708","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-05-24","publication_date":"2008-02-05","legal_status":"Court proceedings terminated"} | US7326708B2 | 05 Feb, 2008 | Court proceedings terminated | 24 May, 2027 | |
| {"application_id":"87342","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"ffc4172272ab426986ef","publication_number":"US7713938B2","cleaned_patent_number":"7713938","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-10-15","publication_date":"2010-05-11","legal_status":"Patented case"} | US7713938B2 | 11 May, 2010 | Patented case | 15 Oct, 2027 | |
| {"application_id":"4488","ingredient":"LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"d085a2058e3c4372af39","publication_number":"US8673927B2","cleaned_patent_number":"8673927","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-04","publication_date":"2014-03-18","legal_status":"Patented case"} | US8673927B2 | 18 Mar, 2014 | Patented case | 04 Nov, 2027 | |
| {"application_id":"128933","ingredient":"LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO XR","family_id":"d085a2058e3c4372af39","publication_number":"US9173859B2","cleaned_patent_number":"9173859","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-11-04","publication_date":"2015-11-03","legal_status":"Patented case"} | US9173859B2 | 03 Nov, 2015 | Patented case | 04 Nov, 2027 | |
| {"application_id":"1322","ingredient":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"QTERNMET XR","family_id":"4b7ba1cd2cc042648767","publication_number":"US8501698B2","cleaned_patent_number":"8501698","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2027-12-20","publication_date":"2013-08-06","legal_status":"Patented case"} | US8501698B2 | 06 Aug, 2013 | Patented case | 20 Dec, 2027 | |
| {"application_id":"2397","ingredient":"CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"INVOKAMET","family_id":"0034c3920e9647578225","publication_number":"US7943788B2","cleaned_patent_number":"7943788","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-01-14","publication_date":"2011-05-17","legal_status":"Patented case"} | US7943788B2 | 17 May, 2011 | Patented case | 14 Jan, 2028 | |
| {"application_id":"2400","ingredient":"CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"INVOKAMET","family_id":"d3b035cdbe3f43fda420","publication_number":"US8513202B2","cleaned_patent_number":"8513202","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-06-03","publication_date":"2013-08-20","legal_status":"Patented case"} | US8513202B2 | 20 Aug, 2013 | Patented case | 03 Jun, 2028 | |
| {"application_id":"95099","ingredient":"ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE","trade_name":"KAZANO","family_id":"a68761525bab406db4fc","publication_number":"US7807689B2","cleaned_patent_number":"7807689","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-06-27","publication_date":"2010-10-05","legal_status":"Patented case"} | US7807689B2 Molecular Formulation | 05 Oct, 2010 | Patented case | 27 Jun, 2028 | |
| {"application_id":"34219","ingredient":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE","trade_name":"QTERNMET XR","family_id":"0844ff11d6e64e509841","publication_number":"US8716251B2","cleaned_patent_number":"8716251","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-09-21","publication_date":"2014-05-06","legal_status":"Granted"} | US8716251B2 | 06 May, 2014 | Granted | 21 Sep, 2028 | |
| {"application_id":"94986","ingredient":"METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE","trade_name":"JANUMET","family_id":"5c8e268d150642aab2ec","publication_number":"US8414921B2","cleaned_patent_number":"8414921","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-01-21","publication_date":"2013-04-09","legal_status":"Patented case"} | US8414921B2 | 09 Apr, 2013 | Patented case | 21 Jan, 2029 | |
| {"application_id":"87266","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"791f672105f54f7991fb","publication_number":"US7579449B2","cleaned_patent_number":"7579449","drug_product_flag":"-","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-01","publication_date":"2009-08-25","legal_status":"Court proceedings terminated"} | US7579449B2 | 25 Aug, 2009 | Court proceedings terminated | 01 Feb, 2029 | |
| {"application_id":"89606","ingredient":"METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE","trade_name":"ACTOPLUS MET","family_id":"14c9530dc238481c900d","publication_number":"US9320714B2","cleaned_patent_number":"9320714","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-02-03","publication_date":"2016-04-26","legal_status":"Granted"} | US9320714B2 Formulation | 26 Apr, 2016 | Granted | 03 Feb, 2029 | |
| {"application_id":"95158","ingredient":"ALOGLIPTIN BENZOATE; METFORMIN HYDROCHLORIDE","trade_name":"KAZANO","family_id":"d9114a3e1e17421280da","publication_number":"US8900638B2","cleaned_patent_number":"8900638","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-05-24","publication_date":"2014-12-02","legal_status":"Granted"} | US8900638B2 Formulation | 02 Dec, 2014 | Granted | 24 May, 2029 | |
| {"application_id":"2396","ingredient":"CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"INVOKAMET","family_id":"d3b035cdbe3f43fda420","publication_number":"US7943582B2","cleaned_patent_number":"7943582","drug_product_flag":"-, Y","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-08-26","publication_date":"2011-05-17","legal_status":"Patented case"} | US7943582B2 | 17 May, 2011 | Patented case | 26 Aug, 2029 | |
| {"application_id":"128944","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"c57d5710bbb34b4bbd01","publication_number":"US9415016B2","cleaned_patent_number":"9415016","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-10-02","publication_date":"2016-08-16","legal_status":"Patented case"} | US9415016B2 | 16 Aug, 2016 | Patented case | 02 Oct, 2029 | |
| {"application_id":"9271","ingredient":"LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"c57d5710bbb34b4bbd01","publication_number":"US10973827B2","cleaned_patent_number":"10973827","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-10-02","publication_date":"2021-04-13","legal_status":"Patented case"} | US10973827B2 | 13 Apr, 2021 | Patented case | 02 Oct, 2029 | |
| {"application_id":"128943","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"c57d5710bbb34b4bbd01","publication_number":"US10022379B2","cleaned_patent_number":"10022379","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2029-10-02","publication_date":"2018-07-17","legal_status":"Patented case"} | US10022379B2 | 17 Jul, 2018 | Patented case | 02 Oct, 2029 | |
| {"application_id":"129630","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"a8cfb2e0910e427380e7","publication_number":"US12115179B2","cleaned_patent_number":"12115179","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-02-11","publication_date":"2024-10-15","legal_status":"Patented case"} | US12115179B2 | 15 Oct, 2024 | Patented case | 11 Feb, 2030 | |
| {"application_id":"129347","ingredient":"LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"c0d9634ba3f048cfbe74","publication_number":"US11911388B2","cleaned_patent_number":"11911388","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-10","publication_date":"2024-02-27","legal_status":"Patented case"} | US11911388B2 | 27 Feb, 2024 | Patented case | 10 Apr, 2030 | |
| {"application_id":"2926","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"TRIJARDY XR","family_id":"9b474d4dce3f44d08a3b","publication_number":"US8551957B2","cleaned_patent_number":"8551957","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-04-14","publication_date":"2013-10-08","legal_status":"Patented case"} | US8551957B2 | 08 Oct, 2013 | Patented case | 14 Apr, 2030 | |
| {"application_id":"128946","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"TRIJARDY XR","family_id":"a8cfb2e0910e427380e7","publication_number":"US10406172B2","cleaned_patent_number":"10406172","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-15","publication_date":"2019-09-10","legal_status":"Granted"} | US10406172B2 Formulation | 10 Sep, 2019 | Granted | 15 Jun, 2030 | |
| {"application_id":"1318","ingredient":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"QTERNMET XR","family_id":"4b7ba1cd2cc042648767","publication_number":"US7919598B2","cleaned_patent_number":"7919598","drug_product_flag":"-","drug_substance_flag":"-, Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-06-16","publication_date":"2011-04-05","legal_status":"Patented case"} | US7919598B2 | 05 Apr, 2011 | Patented case | 16 Jun, 2030 | |
| {"application_id":"2395","ingredient":"CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"INVOKAMET","family_id":"5960844d14fe48dea711","publication_number":"US11576894B2","cleaned_patent_number":"11576894","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-07-06","publication_date":"2023-02-14","legal_status":"Granted"} | US11576894B2 Formulation | 14 Feb, 2023 | Granted | 06 Jul, 2030 | |
| {"application_id":"99113","ingredient":"ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SEGLUROMET","family_id":"83e195a225ea43aaadd8","publication_number":"US8080580B2","cleaned_patent_number":"8080580","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-07-13","publication_date":"2011-12-20","legal_status":"Patented case"} | US8080580B2 Molecular Formulation | 20 Dec, 2011 | Patented case | 13 Jul, 2030 | |
| {"application_id":"99103","ingredient":"ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SEGLUROMET","family_id":"23875e449508455d87ea","publication_number":"US9308204B2","cleaned_patent_number":"9308204","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-21","publication_date":"2016-04-12","legal_status":"Patented case"} | US9308204B2 Formulation | 12 Apr, 2016 | Patented case | 21 Oct, 2030 | |
| {"application_id":"99080","ingredient":"ERTUGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SEGLUROMET","family_id":"23875e449508455d87ea","publication_number":"US9439902B2","cleaned_patent_number":"9439902","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-10-21","publication_date":"2016-09-13","legal_status":"Patented case"} | US9439902B2 | 13 Sep, 2016 | Patented case | 21 Oct, 2030 | |
| {"application_id":"9248","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"c57d5710bbb34b4bbd01","publication_number":"US9155705B2","cleaned_patent_number":"9155705","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-21","publication_date":"2015-10-13","legal_status":"Patented case"} | US9155705B2 | 13 Oct, 2015 | Patented case | 21 Nov, 2030 | |
| {"application_id":"129358","ingredient":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"XIGDUO XR","family_id":"9bbe193f427f4d7a8078","publication_number":"US8685934B2","cleaned_patent_number":"8685934","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-11-26","publication_date":"2014-04-01","legal_status":"Patented case"} | US8685934B2 | 01 Apr, 2014 | Patented case | 26 Nov, 2030 | |
| {"application_id":"94995","ingredient":"LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO","family_id":"8c31d33095a84bf78392","publication_number":"US8846695B2","cleaned_patent_number":"8846695","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2030-12-04","publication_date":"2014-09-30","legal_status":"Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362"} | US8846695B2 | 30 Sep, 2014 | Patent expired due to nonpayment of maintenance fees under 37 cfr 1.362 | 04 Dec, 2030 | |
| {"application_id":"18052","ingredient":"EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"e0221a4a7741495d9682","publication_number":"US10610489B2","cleaned_patent_number":"10610489","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-03-30","publication_date":"2020-04-07","legal_status":"Patented case"} | US10610489B2 | 07 Apr, 2020 | Patented case | 30 Mar, 2031 | |
| {"application_id":"129386","ingredient":"DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"QTERNMET XR","family_id":"60d8d0915b8046e5bff1","publication_number":"US9616028B2","cleaned_patent_number":"9616028","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-12","publication_date":"2017-04-11","legal_status":"Granted"} | US9616028B2 | 11 Apr, 2017 | Granted | 12 May, 2031 | |
| {"application_id":"87261","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"TRIJARDY XR","family_id":"3172922541784e29b519","publication_number":"US11564886B2","cleaned_patent_number":"11564886","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-03-07","publication_date":"2023-01-31","legal_status":"Patented Case"} | US11564886B2 Formulation | 31 Jan, 2023 | Patented Case | 07 Mar, 2032 | |
| {"application_id":"87243","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY XR","family_id":"3172922541784e29b519","publication_number":"US10596120B2","cleaned_patent_number":"10596120","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-09-07","publication_date":"2020-03-24","legal_status":"Patented case"} | US10596120B2 | 24 Mar, 2020 | Patented case | 07 Sep, 2032 | |
| {"application_id":"86175","ingredient":"LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"JENTADUETO XR","family_id":"0a3c5d67d5ba489a965b","publication_number":"US9555001B2","cleaned_patent_number":"9555001","drug_product_flag":"-, Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2033-09-06","publication_date":"2017-01-31","legal_status":"Patented case"} | US9555001B2 | 31 Jan, 2017 | Patented case | 06 Sep, 2033 | |
| {"application_id":"107541","ingredient":"EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"b109e85484344d2d8342","publication_number":"US12263153B2","cleaned_patent_number":"12263153","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-04-03","publication_date":"2025-04-01","legal_status":"Patented case"} | US12263153B2 | 01 Apr, 2025 | Patented case | 03 Apr, 2034 | |
| {"application_id":"31591","ingredient":"EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"70eb830815144990bff1","publication_number":"US11813275B2","cleaned_patent_number":"11813275","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-04-03","publication_date":"2023-11-14","legal_status":"Patented case"} | US11813275B2 | 14 Nov, 2023 | Patented case | 03 Apr, 2034 | |
| {"application_id":"27805","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"71430f9a55cb497db184","publication_number":"US11833166B2","cleaned_patent_number":"11833166","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-04-03","publication_date":"2023-12-05","legal_status":"Patented case"} | US11833166B2 | 05 Dec, 2023 | Patented case | 03 Apr, 2034 | |
| {"application_id":"26837","ingredient":"EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"d4dd6e10985f4c74bdc1","publication_number":"US11666590B2","cleaned_patent_number":"11666590","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-04-03","publication_date":"2023-06-06","legal_status":"Patented case"} | US11666590B2 | 06 Jun, 2023 | Patented case | 03 Apr, 2034 | |
| {"application_id":"27803","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"71430f9a55cb497db184","publication_number":"US10258637B2","cleaned_patent_number":"10258637","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-10-03","publication_date":"2019-04-16","legal_status":"Patented case"} | US10258637B2 | 16 Apr, 2019 | Patented case | 03 Oct, 2034 | |
| {"application_id":"27804","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"71430f9a55cb497db184","publication_number":"US11090323B2","cleaned_patent_number":"11090323","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-10-03","publication_date":"2021-08-17","legal_status":"Patented case"} | US11090323B2 | 17 Aug, 2021 | Patented case | 03 Oct, 2034 | |
| {"application_id":"17961","ingredient":"EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY","family_id":"70eb830815144990bff1","publication_number":"US9949997B2","cleaned_patent_number":"9949997","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-11-17","publication_date":"2018-04-24","legal_status":"Patented case"} | US9949997B2 | 24 Apr, 2018 | Patented case | 17 Nov, 2034 | |
| {"application_id":"27801","ingredient":"EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDE","trade_name":"SYNJARDY XR","family_id":"71430f9a55cb497db184","publication_number":"US9949998B2","cleaned_patent_number":"9949998","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-12-11","publication_date":"2018-04-24","legal_status":"Patented case"} | US9949998B2 | 24 Apr, 2018 | Patented case | 11 Dec, 2034 | |
| {"application_id":"57934","ingredient":"METFORMIN HYDROCHLORIDE","trade_name":"RIOMET ER","family_id":"452467d1f6db4f59ae6a","publication_number":"US9962336B2","cleaned_patent_number":"9962336","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-05-01","publication_date":"2018-05-08","legal_status":"Granted"} | US9962336B2 Formulation | 08 May, 2018 | Granted | 01 May, 2035 |
Latest clinical trials and research studies for this ingredient
| NCT ID | Title | Status | Phase | Conditions | Start Date | Completion Date |
|---|
Manufacturing Locations
Unlock access to all suppliers of Metformin Hydrochloride
Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.